Apheresis: principles and practice
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Bethesda, Md.
AABB Press
2010
|
| Ausgabe: | 3. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XXVI, 715 S. Ill., graph. Darst. |
| ISBN: | 9781563953057 9783805596886 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV037342239 | ||
| 003 | DE-604 | ||
| 005 | 20110729 | ||
| 007 | t | ||
| 008 | 110415s2010 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2010030205 | ||
| 020 | |a 9781563953057 |9 978-1-56395-305-7 | ||
| 020 | |a 9783805596886 |9 978-3-8055-9688-6 | ||
| 035 | |a (OCoLC)724773845 | ||
| 035 | |a (DE-599)BVBBV037342239 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-355 | ||
| 050 | 0 | |a RM173 | |
| 082 | 0 | |a 615/.39 | |
| 084 | |a YU 1800 |0 (DE-625)154189:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Apheresis |b principles and practice |c ed.: Bruce C. McLeod ... |
| 250 | |a 3. ed. | ||
| 264 | 1 | |a Bethesda, Md. |b AABB Press |c 2010 | |
| 300 | |a XXVI, 715 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Hemapheresis | |
| 650 | 4 | |a Blood Component Removal |x methods | |
| 650 | 0 | 7 | |a Apherese |0 (DE-588)4335924-3 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Apherese |0 (DE-588)4335924-3 |D s |
| 689 | 0 | |C b |5 DE-604 | |
| 700 | 1 | |a McLeod, Bruce C. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022495927&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-022495927 | ||
Datensatz im Suchindex
| _version_ | 1804145628946628608 |
|---|---|
| adam_text | Titel: Apheresis
Autor: McLeod, Bruce C.
Jahr: 2010
Table of Contents
Preface..........................................................................xxi
About the Editors.................................................................xxv
1. Development of Apheresis Instrumentation.......................................1
Frank Corbin; Herbert M. Cullis; Emu J. Freireich, MD, DSc (Hon.); Yoichiro Ito, MD;
Robert M. Kellogg, PhD; Allen Latham, Jr.; and Bruce C. McLeod, MD
Colin Centrifuge................................................................2
1 laemonetics Instruments and the Latham Bowl......................................3
NCI-IBM Blood Cell Separator.....................................................5
Sealless Continuous Flow Centrifuge................................................9
Aminco Celltrifuge II and Fenwal CS3000........................................13
IBM 2997/COBE Spectra......................................................14
Membrane Plasma Separation...................................................20
Conclusion...................................................................23
References...................................................................23
2. Applications History.........................................................27
Edwin G. Taft, MD
Manual Plasmapheresis and Plateletpheresis.......................................27
Donor Plasmapheresis and Plateletpheresis by Blood Cell Separator....................28
Pooled Platelets from Whole Blood vs Single-Donor Plateletpheresis...................28
Continuous-Flow Centrifuge.....................................................29
Therapeutic Plateletpheresis.....................................................29
Granulocyte Apheresis.........................................................29
Filtration Leukapheresis........................................................30
Other Normal-Cell Leukapheresis................................................30
Leukapheresis of Pathologic Leukocytes...........................................31
Red Cell Exchange and Related Procedures........................................32
Therapeutic Plasma Exchange...................................................33
Category I Indications for Therapeutic Plasma Exchange.............................33
Non-Category-1 Indications for TPE...............................................38
Conclusion...................................................................38
References...................................................................38
Apheresis: Principles and Practice
3. Physiology of Apheresis.......................................................45
Kendall P. Crookston, MD, PhD. and Deborah J Novak. MD
Anticoagulation...............................................................45
Fluid Shifts...................................................................54
Drug Interactions and Clearance.................................................56
Cellular Loss..................................................................57
Plasma Protein Interactions......................................................59
Adverse Effects...............................................................60
Summary....................................................................65
References...................................................................65
4. Current Instrumentation for Apheresis.........................................71
Edwin A. Burgstaler, MT, HP(ASCP)
Principles of Operation.........................................................71
Instruments for Leukapheresis, Plateletpheresis, and/or Plasma Collection...............73
Instruments for Red Cell and Other Component Collection............................88
Comparison of Donor Apheresis Systems..........................................98
Therapeutic Applications........................................................98
Summary...................................................................108
References..................................................................108
5. Selection and Care of Apheresis Donors.......................................Ill
Christina Anderson, RN, BSN, HP(ASCP)
Selection of Apheresis Donors..................................................Ill
Care of the Apheresis Donor...................................................118
Special Types of Donations.....................................................121
Conclusion..................................................................122
References..................................................................122
6. Automated Donations: Plasma, Red Cells, and Multicomponent
Donor Procedures........................................................125
James W. Smith, MD. PhD
Plasma Donation by Apheresis..................................................126
Red Cell and Multicomponent Donation by Apheresis...............................129
Donor Acceptance, Regulatory Concerns, and Administrative Issues...................133
Summary...................................................................138
References..................................................................139
7. Apheresis Hatelet Collection, Storage, Quality Assessment, and
Clinical Use..............................................................141
Ralph R. Vassalbjr, MD, FACP, and Scott Murphy, MD
Platelet Physiology............................................................141
Platelet Transfusion Dose......................................................146
Liquid Storage of Platelets in Plasma.............................................148
Liquid Storage of Platelets in Platelet Additive Solution..............................154
Ihr
Table of Contents
Assessing Platelet Quality......................................................155
Component Modification......................................................158
Conclusions.................................................................160
References..................................................................160
8. Provision of Apheresis Platelet Transfusions: Patient and
Producer Perspectives....................................................167
77iomas H. Price, MD
Usage Trends................................................................167
Characteristics of Apheresis and Pooled Platelets...................................170
Advantages and Disadvantages of Apheresis Platelets...............................172
Summary...................................................................176
References..................................................................176
9. Matched Apheresis Platelets.................................................179
Janice G. McFarland, MD
HLA Alloimmunization and Platelet Transfusions..................................180
ABH Antigens and Platelet Transfusion..........................................182
Platelet-Specific Antigens and Platelet Transfusions.................................183
Diagnosis of Alloimmune Refractoriness..........................................185
Matched Platelets in the Management of the Alloimmunized Patient...................187
Elements of a Matched Donor Program..........................................192
References..................................................................194
10. Bacterial Contamination of Platelet Products..................................199
Sara C. Koenig, MD; Mark E. Brecher, MD; and Yara A. Park, MD
Clinical Presentation of Septic Transfusion Reactions...............................201
Organisms and Sources........................................................202
Methods to Reduce the Risk of Transfusion-Acquired Sepsis.........................202
Conclusion..................................................................210
References..................................................................210
11. Granulocyte (Neutrophil) Transfusion.........................................215
Ronald G. Strauss, MD
Neutrophil (PMN) Physiology...................................................216
Clinical Experience and Limitations of Granulocyte Transfusions.....................217
Technology of Granulocyte Collection and Transfusion.............................223
Future of Granulocyte (Neutrophil) Transfusions...................................225
References..................................................................225
12. Management of the Therapeutic Apheresis Patient.............................229
Vishesh Chhibber, MD, and Karen E. King, MD
The Therapeutic Apheresis Service..............................................229
The Therapeutic Apheresis Consultation.........................................230
Extracorporeal Volume Evaluation and Management...............................231
Apheresis. Principles and Practice
Vascular Access..............................................................233
Technical Difficulties and Catheter-Related Complications...........................237
Intraprocedural Care and Monitoring............................................238
Management of Special Patient Populations.......................................240
Management of Adverse Events.................................................244
Orders......................................................................246
Records.....................................................................246
Conclusion..................................................................247
References..................................................................247
13. Therapeutic Leukocyte and Platelet Depletion.................................251
Nicholas Bandarenko, MD, and Evelyn Lockhart, MD
Hyperleukocytosis and Leukostasis..............................................251
Selective Leukocyte Apheresis..................................................256
Thrombocytosis..............................................................259
Conclusion..................................................................263
References..................................................................264
14. Basic Principles of Therapeutic Blood Exchange...............................269
Robert Weinstein, MD
Modeling the Effects of Plasma Exchange.........................................270
Reduction of Blood Constituent Levels with Therapeutic Plasma Exchange.............277
The Intensity of Therapeutic Plasma Exchange: Volume and Schedule.................286
Replacement Fluids for Plasma Exchange.........................................288
Conclusions..................................................................289
References..................................................................289
15. Therapeutic Apheresis in Neurologic Disorders................................295
Bruce C. McLeod, MD
Guillain-Barré Syndrome.......................................................295
Chronic Inflammatory Demyelinaung Polyneuropathy..............................299
Peripheral Neuropathy with Monoclonal Gammopathy..............................301
Myasthenia Gravis............................................................302
Lambert-Eaton Myasthenic Syndrome............................................304
Stiff-Person Syndrome.........................................................305
Other Paraneoplastic CNS Syndromes............................................305
Multiple Sclerosis and Neuromyelitis Optica.......................................307
Other Neurologic Syndromes...................................................310
Summary...................................................................311
References..................................................................311
16. Therapeutic Plasma Exchange in Hematologic Diseases and Dysproteinemias.....319
Joseph E. Kiss, MD
Thrombotic Thrombocytopenic Purpura and other Thrombotic Microangiopathies.......320
ABO-Mismatched Hematopoietic Progenitor Cell Transplantation.....................330
Acquired Aplastic Anemia and Pure Red Cell Aplasia...............................331
ni
Table of Contents
Autoimmune Hemolytic Anemia................................................332
Immune Thrombocytopenic Purpura............................................334
Coagulation Factor Inhibitors...................................................335
Posttransfusion Purpura.......................................................336
Therapeutic Plasma Exchange in Dysproteinemias.................................337
Summary...................................................................339
References..................................................................340
17. Therapeutic Plasma Exchange for Renal and Rheumatic Diseases................349
Andre A. Kaplan. MD, FACP, FASN
GBM-Antibody-Mediated Disease (Goodpasture Syndrome)..........................350
Rapidly Progressive Glomerulonephritis Not Associated with Anti-GBM................351
Renal Failure in Multiple Myeloma..............................................353
IgA Nephropathy and Henoch-Schonlein Purpura..................................355
Systemic Lupus Erythematosus.................................................356
Lupus Anticoagulant, Anticardiolipin Antibodies, and the Antiphospholipid Syndrome . .. 357
Scleroderma.................................................................358
Cryoglobulinemia............................................................360
I lemolytic Uremic Syndrome...................................................361
Renal Transplantation.........................................................364
References..................................................................364
18. Apheresis in Solid Organ Transplantation.....................................371
Marisa B. Marques, MD
Renal Transplantation.........................................................372
I leart Transplantation.........................................................379
Lung Transplantation.........................................................382
Liver Transplantation.........................................................383
Conclusion..................................................................385
References..................................................................385
19. Red Cell Exchange and Other Therapeutic Alterations of Red Cell Mass..........391
Beth H. Shaz, MD
Techniques for Red Cell Exchange..............................................391
Indications for Red Cell Exchange...............................................394
Indications for Red Cell Depletion...............................................403
References..................................................................406
20. Selective Extraction of Plasma Constituents...................................411
Jeffrey L. Winters, MD
Double Filtration Plasmapheresis................................................412
Nonspecific Immunoadsorption.................................................415
Specific Immunoadsorption: Glycosorb...........................................427
LDL Apheresis...............................................................427
Conclusion..................................................................436
References..................................................................437
Apheresis: Principles and Practice
21. Therapeutic Apheresis in Pediatric Patients....................................445
Haewon C. Kim, MD
Special Considerations in Application of Apheresis in Pediatric Patients................446
Procedural Modifications for Pediatric Apheresis...................................449
Intravascular Volume Management..............................................450
Pediatric Apheresis Procedures.................................................452
Pediatric Diseases Treated by Therapeutic Apheresis...............................457
Adverse Effects..............................................................457
References..................................................................461
22. Hematopoietic Stem Cell Transplantation: An Overview.........................465
John R. Wingard, MD; Baldeep Wirk, MD; and Randy Brown, MD
Historical Perspective.........................................................465
The Transplant Procedure.....................................................469
Indications for HSCT..........................................................475
Future Trends...............................................................476
References..................................................................478
23. Mobilization and Collection of Peripheral Blood Hematopoietic
Progenitor Cells..........................................................483
Joseph Schwartz, MD; Anand Padmanabhan, MD, PhD; Richard 0. Francis, MD, PhD;
and Michael L. Linenberger, MD, FACP
Clinical Applications of Blood HPCs..............................................484
Mobilization of HPCs..........................................................485
HPC Collection by Apheresis...................................................494
Standards and Regulatory Considerations for HPC(A) Products.......................496
Special Considerations for Mobilization and Collection of Autologous HPC(A)...........500
Adverse Events..............................................................501
References..................................................................507
24. Receipt, Processing, and Infusion of Hematopoietic Progenitor and
Therapeutic Cells.........................................................523
Kathryn M. Bushneil, MT(ASCP), and Zbigniew M. Szczepiorkowski, MD, PhD, FCAP
Types of Hematopoietic Stem Cell Transplantation.................................524
Characteristics of Hematopoietic Progenitor Cell Products...........................524
Hematopoietic Progenitor Cells-Product Types....................................525
Collection, Processing, Issue, and Administration...................................526
References..................................................................544
25. Regenerative Medicine.......................................................549
Daniela S. Krause, MD, PhD, and David T. Scadden, MD
Regeneration from Endogenous Cells............................................550
Exogenous Tissue Regeneration by Transplantation................................553
Clinical Applications of Cells with Regenerative Potential............................557
References..............................................................___559
XVBÍ
Table of Contents
26. Autologous Cellular Immunotherapies........................................563
David W. O Neill, MD
Active Cellular Immunotherapies (Dendritic Cell/Antigen-Presenting Cell Vaccines)......564
Adoptive Cell Transfer........................................................573
Summary...................................................................580
References..................................................................580
27. Allogeneic Adoptive Immunotherapy with Apheresis Products...................589
David L Porter, MD, and Joseph H. Antin, MD
Graft-vs-Tumor Effects in Murine Models of Transplantation.........................590
Evidence for a Graft-vs-Tumor Effect in Clinical Transplantation.....................590
Treatment of Relapsed Leukemia After Allogeneic Transplantation:
Graft-vs-Leukemia Induction with Donor Lymphocyte Infusions....................593
Toxicity of Adoptive Immunotherapy............................................599
New Strategies of Adoptive Immunotherapy......................................600
Prophylactic DU.............................................................603
Cytokine-Mediated Immunotherapy.............................................604
Adoptive Immunotherapy for Nonrelapse Complications After Allogeneic HSCT........605
Conclusion..................................................................605
References..................................................................606
28. Photopheresis..............................................................615
Jaehyuk Choi, MD, PhD, and Francine M. Foss, MD
ECP Procedure..............................................................615
Therapeutic Applications of Photopheresis........................................618
Clinical Trials of ECP in Autoimmune Disorders...................................624
Mechanisms of ECP..........................................................629
Summary...................................................................629
References..................................................................629
29. Cellular Gene Therapy......................................................635
P. Dayanand Borge, Jr, MD, PhD, and Harvey G. Klein, MD
Basic Requirements of Gene Transfer Technology.................................636
Desirable Properties of a Gene Delivery Vehicle...................................637
Applications of Cellular Gene Therapy...........................................638
Regulatory and Safety Issues...................................................645
Future Prospects.............................................................645
References..................................................................646
30. Regulatory Environment for Apheresis Facilities and Personnel.................651
Michelle A. Vauthrin, MT(ASCP)SBB, and Julian Ferschke, BS
Regulatory Agencies..........................................................651
Professional Organizations.....................................................656
Summary...................................................................659
References..................................................................659
xix
Apherests: Principles and Practice
31. Principles of Quality Management for Apheresis Facilities.......................663
Christopher Chun. MT. HPiASCP)
FDA Criteria.................................................................664
AABB Criteria...............................................................665
FACT Criteria................................................................666
Minimal Quality System Elements...............................................666
Conclusion..................................................................677
References..................................................................678
Suggested Reading............................................................678
32. Quality Management of Apheresis Personnel...................................681
Wanda B. Koetz, RN, HPiASCP)
Background.................................................................681
Employee Categories and Roles.................................................683
Management of Individuals.....................................................685
Management of the Apheresis Unit..............................................686
Summary...................................................................689
References..................................................................689
Index...........................................................................691
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV037342239 |
| callnumber-first | R - Medicine |
| callnumber-label | RM173 |
| callnumber-raw | RM173 |
| callnumber-search | RM173 |
| callnumber-sort | RM 3173 |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| classification_rvk | YU 1800 |
| ctrlnum | (OCoLC)724773845 (DE-599)BVBBV037342239 |
| dewey-full | 615/.39 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.39 |
| dewey-search | 615/.39 |
| dewey-sort | 3615 239 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 3. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01405nam a2200409zc 4500</leader><controlfield tag="001">BV037342239</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110729 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110415s2010 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2010030205</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781563953057</subfield><subfield code="9">978-1-56395-305-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783805596886</subfield><subfield code="9">978-3-8055-9688-6</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)724773845</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV037342239</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM173</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.39</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YU 1800</subfield><subfield code="0">(DE-625)154189:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Apheresis</subfield><subfield code="b">principles and practice</subfield><subfield code="c">ed.: Bruce C. McLeod ...</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Bethesda, Md.</subfield><subfield code="b">AABB Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXVI, 715 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hemapheresis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Blood Component Removal</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Apherese</subfield><subfield code="0">(DE-588)4335924-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Apherese</subfield><subfield code="0">(DE-588)4335924-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McLeod, Bruce C.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022495927&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-022495927</subfield></datafield></record></collection> |
| id | DE-604.BV037342239 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T23:22:29Z |
| institution | BVB |
| isbn | 9781563953057 9783805596886 |
| language | English |
| lccn | 2010030205 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-022495927 |
| oclc_num | 724773845 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | XXVI, 715 S. Ill., graph. Darst. |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | AABB Press |
| record_format | marc |
| spelling | Apheresis principles and practice ed.: Bruce C. McLeod ... 3. ed. Bethesda, Md. AABB Press 2010 XXVI, 715 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Hemapheresis Blood Component Removal methods Apherese (DE-588)4335924-3 gnd rswk-swf Apherese (DE-588)4335924-3 s b DE-604 McLeod, Bruce C. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022495927&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Apheresis principles and practice Hemapheresis Blood Component Removal methods Apherese (DE-588)4335924-3 gnd |
| subject_GND | (DE-588)4335924-3 |
| title | Apheresis principles and practice |
| title_auth | Apheresis principles and practice |
| title_exact_search | Apheresis principles and practice |
| title_full | Apheresis principles and practice ed.: Bruce C. McLeod ... |
| title_fullStr | Apheresis principles and practice ed.: Bruce C. McLeod ... |
| title_full_unstemmed | Apheresis principles and practice ed.: Bruce C. McLeod ... |
| title_short | Apheresis |
| title_sort | apheresis principles and practice |
| title_sub | principles and practice |
| topic | Hemapheresis Blood Component Removal methods Apherese (DE-588)4335924-3 gnd |
| topic_facet | Hemapheresis Blood Component Removal methods Apherese |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=022495927&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT mcleodbrucec apheresisprinciplesandpractice |